Last reviewed · How we verify

NCT05443477

Hericium Erinaceus Mycelium and Probiotic of the Grape King Bio on Symptoms of Premenstrual Syndrome

Status unknown NA Last updated 5 July 2022
What this trial tests

NA trial testing Hericium Erinaceus Mycelium in Premenstrual Syndrome in 105 participants. Status unknown.

Timeline
8 June 2021
Primary endpoint
7 January 2023
7 January 2023

Quick facts

Lead sponsorChung Shan Medical University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designsingle group
Maskingdouble
Primary purposetreatment
Enrollment105
Start date8 June 2021
Primary completion7 January 2023
Estimated completion7 January 2023
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Chung Shan Medical University

Who can join

Adults 20 to 45, female only, with Premenstrual Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this experiment is to evaluate the efficacy of supplemental health food Grape King Hericium erinaceus Mycelium Capsules and Grape King Probiotic Capsules in improving physical and psychological symptoms, blood oxidative stress and inflammation indicators in women with premenstrual syndrome.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Premenstrual Syndrome

Currently open trials in the same condition.

Other Chung Shan Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05443477.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing